Clinical Trials Browser

Phase 3 × Thymoma × Drug Therapy × Clear all

NCT06402708 2024-05-10

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Phase 3 Recruiting

Thymoma